Century Therapeutics (IPSC) Short-term Investments (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Short-term Investments data on file, last reported at $83.8 million in Q1 2026.

• On a quarterly basis, Short-term Investments fell 26.05% year-over-year to $83.8 million in Q1 2026; TTM through Mar 2026 was $83.8 million, a 26.05% decrease from a year earlier, with the FY2025 full-year figure at $55.3 million, down 57.77% from the prior year.
• Short-term Investments for Q1 2026 stood at $83.8 million, up from $55.3 million in the prior quarter.
• Over the last five years, Short-term Investments for IPSC reached as high as $266.0 million in Q2 2022 and fell as low as $55.3 million in Q4 2025.
• Historically, Short-term Investments has averaged $145.8 million across 5 years, with a median of $130.9 million in 2024.
• Across the five-year window, Short-term Investments surged 112.28% in 2022 and plunged 65.43% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $231.2 million in 2022, then slumped by 45.76% to $125.4 million in 2023, then grew by 4.34% to $130.9 million in 2024, then plunged by 57.77% to $55.3 million in 2025, then surged by 51.56% to $83.8 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $83.8 million in Q1 2026, $55.3 million in Q4 2025, and $77.2 million in Q3 2025.